ALKS FY 2020 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.0B-11.3% YoY

Gross Profit

$860M82.8% margin

Operating Income

-$112M-10.8% margin

Net Income

-$111M-10.7% margin

EPS (Diluted)

$-0.70

Cash Flow

Operating Cash Flow

$83M

Free Cash Flow

$41M

Stock-Based Comp.

$90M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$883M

Stockholders' Equity

$1.1B

Cash & Equivalents

$273M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$1.2B	-11.3%
Gross Profit	$860M	$991M	-13.1%
Operating Income	-$112M	-$175M	+35.9%
Net Income	-$111M	-$197M	+43.6%